Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/27/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
05/27/20241:30AMGlobeNewswire Inc.McPhy Energy: Hytlantic and McPhy agree to terminate cooperation agreementEU:MCPHYMcphy Energy
05/27/20241:30AMGlobeNewswire Inc.ALSTOM SA: Alstom launches a share capital increase with preferential subscription rights for an amount of approximately €1 billion, thus executing the final step of the announced €2 billion deleveraging planTG:AOMDAlstom
05/27/20241:30AMGlobeNewswire Inc.ALSTOM SA: Alstom launches a share capital increase with preferential subscription rights for an amount of approximately €1 billion, thus executing the final step of the announced €2 billion deleveraging planEU:ALOAlstom
05/27/20241:30AMGlobeNewswire Inc.ALSTOM SA: Alstom lance une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant d’environ 1 milliard d’euros, dernière étape du plan de désendettement annoncé de 2 milliards d’eurosTG:AOMDAlstom
05/27/20241:30AMGlobeNewswire Inc.McPhy Energy: Hytlantic and McPhy agree to terminate cooperation agreementLSE:0QTFMcphy Energy Sas
05/27/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
05/27/20241:30AMGlobeNewswire Inc.McPhy Energy : Hytlantic et McPhy conviennent de mettre fin à leur accord de coopérationLSE:0QTFMcphy Energy Sas
05/27/20241:30AMGlobeNewswire Inc.McPhy Energy : Hytlantic et McPhy conviennent de mettre fin à leur accord de coopérationTG:M6PMcphy Energy
05/27/20241:30AMGlobeNewswire Inc.McPhy Energy : Hytlantic et McPhy conviennent de mettre fin à leur accord de coopérationEU:MCPHYMcphy Energy
05/27/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
05/27/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
05/27/20241:30AMGlobeNewswire Inc.ALSTOM SA: Alstom lance une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant d’environ 1 milliard d’euros, dernière étape du plan de désendettement annoncé de 2 milliards d’eurosEU:ALOAlstom
05/27/20241:30AMGlobeNewswire Inc.McPhy Energy: Hytlantic and McPhy agree to terminate cooperation agreementTG:M6PMcphy Energy
05/27/20241:26AMPR Newswire (US)Strauss Group's Reports First Quarter 2024 Results
05/27/20241:24AMAlliance NewsAlliance NewsSouth Korea, China, Japan vow to ramp up cooperation in rare summit
05/27/20241:21AMAlliance NewsAlliance NewsChina Premier Li meets Samsung boss, vows to help foreign firmsLSE:BC94Samsung El.144a
05/27/20241:15AMAlliance NewsAlliance NewsPRESS: Persimmon mulling offer for L&G's Cala unit - Sky NewsLSE:LGENLegal & General Group Plc
05/27/20241:15AMAlliance NewsAlliance NewsPRESS: Persimmon mulling offer for L&G's Cala unit - Sky NewsLSE:PSNPersimmon Plc
05/27/20241:15AMAlliance NewsAlliance NewsPRESS: Persimmon mulling offer for L&G's Cala unit - Sky NewsLSE:PSNPersimmon Plc
05/27/20241:15AMAlliance NewsAlliance NewsPRESS: Persimmon mulling offer for L&G's Cala unit - Sky NewsLSE:LGENLegal & General Group Plc
05/27/20241:09AMPR Newswire (US)VTT to increase Finland's expertise in developing clean energy solutions
05/27/20241:00AMGlobeNewswire Inc.Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myelomaBIT:1SANSanofi
05/27/20241:00AMGlobeNewswire Inc.Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myelomaEU:SANSanofi
05/27/20241:00AMGlobeNewswire Inc.Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myelomaBIT:SANFSanofi
05/27/20241:00AMGlobeNewswire Inc.Start of Day Message
05/27/20241:00AMGlobeNewswire Inc.Corbion reports the progress of its € 20 million share buyback program 20 May – 24 May 2024EU:CRBNCorbion N.V.
05/27/20241:00AMGlobeNewswire Inc.Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myelomaTG:SNWSanofi
05/27/20241:00AMGlobeNewswire Inc.Communiqué de presse : La FDA accorde un examen prioritaire au Sarclisa pour le traitement des patients atteints d’un myélome multiple nouvellement diagnostiqué non éligibles à une transplantationBIT:SANFSanofi
05/27/20241:00AMGlobeNewswire Inc.Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myelomaEU:SANSanofi